![Lee Golden](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Patrimonio netto: 7 M $ in data 30/06/2026
Dr. Lee S.
Golden, MD, is an Independent Director at Cadrenal Therapeutics, Inc. and a Chief Medical Officer & Executive Vice President at PTC Therapeutics, Inc. He is on the Board of Directors at Cadrenal Therapeutics, Inc. Dr. Golden was previously employed as a Chief Medical Officer by Espero Pharmaceuticals, Inc., a Chief Medical Officer by Gemphire Therapeutics, Inc., a Head-Pulmonary by Mesoblast Ltd., a Head-Cardiovascular & Blood Disorders by Eisai, Inc., a Senior Director-US Medical by Actelion Pharmaceuticals US, Inc., and a Medical Director by Pfizer Inc. He also served on the board at Coagulation Sciences LLC.
He received his undergraduate degree from the University of Michigan and a doctorate degree from New York University School of Medicine.
| Società | Data | Numero di azioni | Valutazione | Data di valutazione |
|---|---|---|---|---|
| 10/04/2026 | 79.964 ( 0,1% ) | 7 M $ | 30/06/2026 | |
| 27/07/2026 | 1.667 ( 0,06% ) | 5 568 $ | 30/06/2026 |
| Società | Posizione | Inizio |
|---|---|---|
| PTC THERAPEUTICS, INC. | Direttore Tecnico/Scientifico/R&S | 01/01/2022 |
| CADRENAL THERAPEUTICS, INC. | Direttore/Membro del Consiglio | 24/11/2025 |
| Società | Posizione | Fine |
|---|---|---|
Espero Pharmaceuticals, Inc.
 Espero Pharmaceuticals, Inc. Medical DistributorsDistribution Services Manufactures and supplies drugs related to cardiovascular | Direttore Tecnico/Scientifico/R&S | 01/05/2020 |
| METAVIA INC. | Direttore Tecnico/Scientifico/R&S | 18/09/2018 |
| MESOBLAST LIMITED | Corporate Officer/Principal | 01/10/2016 |
Eisai, Inc.
 Eisai, Inc. Pharmaceuticals: MajorHealth Technology Manufacturers pharmaceutical products | Corporate Officer/Principal | 01/07/2011 |
Actelion Pharmaceuticals US, Inc.
 Actelion Pharmaceuticals US, Inc. Pharmaceuticals: MajorHealth Technology Manufactures, distributes and markets drugs | Corporate Officer/Principal | 01/03/2008 |
Attive
Inattive
Società nel listino
Aziende private
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
| Aziende private | 11 |
|---|---|
Pfizer Inc.
 Pfizer Inc. Pharmaceuticals: MajorHealth Technology Engages in discovery, development, manufacturing, marketing, sale and distribution of biopharmaceutical products & ingredients | Health Technology |
PTC Therapeutics, Inc.
 PTC Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops, manufactures and markets clinically differentiated medicines for neurodegenerative diseases | Health Technology |
Eisai, Inc.
Eisai, Inc. Pharmaceuticals: MajorHealth Technology Manufacturers pharmaceutical products | Health Technology |
University of Michigan
 University of Michigan Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Mesoblast Ltd.
 Mesoblast Ltd. BiotechnologyHealth Technology Engages in the development and commercialization of biological and adult stem cells products | Health Technology |
Actelion Pharmaceuticals US, Inc.
Actelion Pharmaceuticals US, Inc. Pharmaceuticals: MajorHealth Technology Manufactures, distributes and markets drugs | Health Technology |
New York University School of Medicine
 New York University School of Medicine Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Coagulation Sciences LLC
 Coagulation Sciences LLC Medical/Nursing ServicesHealth Services Provides blood-testing solutions | Health Services |
Gemphire Therapeutics, Inc.
 Gemphire Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops and commercializes therapies for the treatment of Dyslipidemia | Health Technology |
Espero Pharmaceuticals, Inc.
Espero Pharmaceuticals, Inc. Medical DistributorsDistribution Services Manufactures and supplies drugs related to cardiovascular | Distribution Services |
Cadrenal Therapeutics, Inc.
 Cadrenal Therapeutics, Inc. BiotechnologyHealth Technology Operates as a clinical-stage biopharmaceutical company that develops novel therapy with orphan drug indication | Health Technology |
Seleziona la tua edizione
Tutte le informazioni finanziarie adattate in base al livello nazionale
